Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Smoking cessation treatment in community-based substance abuse rehabilitation programs.

Reid MS, Fallon B, Sonne S, Flammino F, Nunes EV, Jiang H, Kourniotis E, Lima J, Brady R, Burgess C, Arfken C, Pihlgren E, Giordano L, Starosta A, Robinson J, Rotrosen J.

J Subst Abuse Treat. 2008 Jul;35(1):68-77. Epub 2007 Oct 24.

PMID:
17951021
2.

Smoking cessation treatment among patients in community-based substance abuse rehabilitation programs: exploring predictors of outcome as clues toward treatment improvement.

Reid MS, Jiang H, Fallon B, Sonne S, Rinaldi P, Turrigiano E, Arfken C, Robinson J, Rotrosen J, Nunes EV.

Am J Drug Alcohol Abuse. 2011 Sep;37(5):472-8. doi: 10.3109/00952990.2011.596981.

3.

Varying nicotine patch dose and type of smoking cessation counseling.

Jorenby DE, Smith SS, Fiore MC, Hurt RD, Offord KP, Croghan IT, Hays JT, Lewis SF, Baker TB.

JAMA. 1995 Nov 1;274(17):1347-52.

PMID:
7563558
4.

Predicting smoking cessation. Who will quit with and without the nicotine patch.

Kenford SL, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB.

JAMA. 1994 Feb 23;271(8):589-94.

PMID:
8301790
6.

A randomized trial of concurrent smoking-cessation and substance use disorder treatment in stimulant-dependent smokers.

Winhusen TM, Brigham GS, Kropp F, Lindblad R, Gardin JG 2nd, Penn P, Hodgkins C, Kelly TM, Douaihy A, McCann M, Love LD, DeGravelles E, Bachrach K, Sonne SC, Hiott B, Haynes L, Sharma G, Lewis DF, VanVeldhuisen P, Theobald J, Ghitza U.

J Clin Psychiatry. 2014 Apr;75(4):336-43. doi: 10.4088/JCP.13m08449.

7.
8.

Evaluating Nicotine Craving, Withdrawal, and Substance Use as Mediators of Smoking Cessation in Cocaine- and Methamphetamine-Dependent Patients.

Magee JC, Lewis DF, Winhusen T.

Nicotine Tob Res. 2016 May;18(5):1196-201. doi: 10.1093/ntr/ntv121. Epub 2015 Jun 5.

PMID:
26048168
9.

Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.

Hurt RD, Dale LC, Fredrickson PA, Caldwell CC, Lee GA, Offord KP, Lauger GG, Marŭsić Z, Neese LW, Lundberg TG.

JAMA. 1994 Feb 23;271(8):595-600.

PMID:
8301791
11.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
12.

The nicotine patch in smoking cessation. A randomized trial with telephone counseling.

Westman EC, Levin ED, Rose JE.

Arch Intern Med. 1993 Aug 23;153(16):1917-23.

PMID:
8250653
13.
14.

The transdermal nicotine patch: results of a randomised placebo-controlled trial.

Richmond RL, Harris K, de Almeida Neto A.

Med J Aust. 1994 Jul 18;161(2):130-5.

PMID:
8028537
15.

Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone.

Rose JE, Behm FM, Westman EC, Levin ED, Stein RM, Ripka GV.

Clin Pharmacol Ther. 1994 Jul;56(1):86-99.

PMID:
8033499
16.

Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment.

Rose JE, Herskovic JE, Behm FM, Westman EC.

Nicotine Tob Res. 2009 Sep;11(9):1067-75. doi: 10.1093/ntr/ntp103. Epub 2009 Jun 30.

PMID:
19567826
17.

Treating smokers before the quit date: can nicotine patches and denicotinized cigarettes reduce cravings?

Rezaishiraz H, Hyland A, Mahoney MC, O'Connor RJ, Cummings KM.

Nicotine Tob Res. 2007 Nov;9(11):1139-46.

PMID:
17978987
19.

Electronic cigarettes for smoking cessation: a randomised controlled trial.

Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, Walker N.

Lancet. 2013 Nov 16;382(9905):1629-37. doi: 10.1016/S0140-6736(13)61842-5. Epub 2013 Sep 9.

PMID:
24029165
20.

Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia.

George TP, Ziedonis DM, Feingold A, Pepper WT, Satterburg CA, Winkel J, Rounsaville BJ, Kosten TR.

Am J Psychiatry. 2000 Nov;157(11):1835-42.

PMID:
11058482

Supplemental Content

Support Center